Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HTVOV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-CD25-IR700 conjugate (Rakuten Medical)
|
|||||
| Synonyms |
Anti-CD25-IR700 conjugate
Click to Show/Hide
|
|||||
| Organization |
Rakuten Medical, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Head and neck cancer [ICD11:2B60-2B6E]
Clinical candidate
Skin squamous cell carcinoma [ICD11:2C31]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Interferon-stimulated gene 20 kDa protein (ISG20)
|
Antigen Info | ||||
| Payload Name |
IRDye 700DX
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines.
|
|||||
| Combination Type |
Sarotalocan
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.